AI-generated summary
The authors studied how red (660 nm) and near-infrared (780 nm) low-level laser light affected melanoma cells in vitro, comparing non-pigmented and pigmented lines, and tested red laser in melanoma-bearing mice. They report that amelanotic cells did not respond to near-infrared light, pigmented cells responded differently depending on dose, and mice given red laser had smaller tumors and longer survival than controls. These are laboratory and animal findings only.
- Who or what was studied
- Melanoma cell lines (amelanotic SK-MEL-37 and melanotic B16F10) in vitro, and melanoma-bearing mice in vivo; the number of mice is not stated in the abstract.
- Wavelengths
- 780, 660 nm
- Limits stated in the abstract
- Findings come from cell cultures and mice, not humans, and the abstract does not state the number of animals.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm, 660 nm
- Energy density (fluence)
- 150 J/cm2, 30 J/cm2
- Power
- 40 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Near-infrared, Dose, Photobiomodulation therapy, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.